StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP)

Investment analysts at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a report issued on Tuesday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Down 7.6 %

NYSE RVP opened at $0.72 on Tuesday. The stock’s 50-day moving average price is $1.00 and its 200-day moving average price is $1.07. The company has a market capitalization of $21.56 million, a P/E ratio of -2.77 and a beta of 2.08. The company has a quick ratio of 6.54, a current ratio of 9.51 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 52 week low of $0.71 and a 52 week high of $1.34.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. The firm had revenue of $6.03 million during the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.